Literature DB >> 21535475

Gram-positive bacterial superantigen outside-in signaling causes toxic shock syndrome.

Amanda J Brosnahan1, Patrick M Schlievert.   

Abstract

Staphylococcus aureus and Streptococcus pyogenes (group A streptococci) are Gram-positive pathogens capable of producing a variety of bacterial exotoxins known as superantigens. Superantigens interact with antigen-presenting cells (APCs) and T cells to induce T cell proliferation and massive cytokine production, which leads to fever, rash, capillary leak and subsequent hypotension, the major symptoms of toxic shock syndrome. Both S. aureus and group A streptococci colonize mucosal surfaces, including the anterior nares and vagina for S. aureus, and the oropharynx and less commonly the vagina for group A streptococci. However, due to their abilities to secrete a variety of virulence factors, the organisms can also cause illnesses from the mucosa. This review provides an updated discussion of the biochemical and structural features of one group of secreted virulence factors, the staphylococcal and group A streptococcal superantigens, and their abilities to cause toxic shock syndrome from a mucosal surface. The main focus of this review, however, is the abilities of superantigens to induce cytokines and chemokines from epithelial cells, which has been linked to a dodecapeptide region that is relatively conserved among all superantigens and is distinct from the binding sites required for interactions with APCs and T cells. This phenomenon, termed outside-in signaling, acts to recruit adaptive immune cells to the submucosa, where the superantigens can then interact with those cells to initiate the final cytokine cascades that lead to toxic shock syndrome.
© 2011 The Authors Journal compilation © 2011 FEBS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21535475      PMCID: PMC3165073          DOI: 10.1111/j.1742-4658.2011.08151.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  157 in total

1.  Reemergence of staphylococcal toxic shock syndrome in Minneapolis-St. Paul, Minnesota, during the 2000-2003 surveillance period.

Authors:  Patrick M Schlievert; Timothy J Tripp; Marnie L Peterson
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

2.  Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk.

Authors:  B C Herold; L C Immergluck; M C Maranan; D S Lauderdale; R E Gaskin; S Boyle-Vavra; C D Leitch; R S Daum
Journal:  JAMA       Date:  1998-02-25       Impact factor: 56.272

3.  Refined structures of three crystal forms of toxic shock syndrome toxin-1 and of a tetramutant with reduced activity.

Authors:  G S Prasad; R Radhakrishnan; D T Mitchell; C A Earhart; M M Dinges; W J Cook; P M Schlievert; D H Ohlendorf
Journal:  Protein Sci       Date:  1997-06       Impact factor: 6.725

4.  An early favorable outcome of streptococcal toxic shock syndrome may require a combination of antimicrobial and intravenous gamma globulin therapy together with activated protein C.

Authors:  Lawrence A Cone; Richard A Stone; Patrick M Schlievert; Ronald A Sneider; Andrew M Rubin; Kenneth Jesser; Stacey W Renker
Journal:  Scand J Infect Dis       Date:  2006

5.  The crystal structure of staphylococcal enterotoxin type D reveals Zn2+-mediated homodimerization.

Authors:  M Sundström; L Abrahmsén; P Antonsson; K Mehindate; W Mourad; M Dohlsten
Journal:  EMBO J       Date:  1996-12-16       Impact factor: 11.598

6.  Analysis of the superantigenic activity of mutant and allelic forms of streptococcal pyrogenic exotoxin A.

Authors:  J B Kline; C M Collins
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

7.  Persistent neuropsychological sequelae of toxic shock syndrome.

Authors:  K A Rosene; M K Copass; L S Kastner; C M Nolan; D A Eschenbach
Journal:  Ann Intern Med       Date:  1982-06       Impact factor: 25.391

Review 8.  Lactational amenorrhea as a risk factor for group a streptococcal vaginitis.

Authors:  Micelle C Meltzer; Jane R Schwebke
Journal:  Clin Infect Dis       Date:  2008-05-15       Impact factor: 9.079

9.  Staphylococcal toxic shock syndrome erythroderma is associated with superantigenicity and hypersensitivity.

Authors:  Chandy C John; Micah Niermann; Bazak Sharon; Marnie L Peterson; David M Kranz; Patrick M Schlievert
Journal:  Clin Infect Dis       Date:  2009-12-15       Impact factor: 9.079

10.  Group A beta-hemolytic streptococcal vulvovaginitis: a recurring problem.

Authors:  P A O'Connor; W J Oliver
Journal:  Pediatr Emerg Care       Date:  1985-06       Impact factor: 1.454

View more
  46 in total

1.  Streptococcus pyogenes Endopeptidase O Contributes to Evasion from Complement-mediated Bacteriolysis via Binding to Human Complement Factor C1q.

Authors:  Mariko Honda-Ogawa; Tomoko Sumitomo; Yasushi Mori; Dalia Talat Hamd; Taiji Ogawa; Masaya Yamaguchi; Masanobu Nakata; Shigetada Kawabata
Journal:  J Biol Chem       Date:  2017-01-30       Impact factor: 5.157

2.  Superantigens of Staphylococcus aureus from patients with diabetic foot ulcers.

Authors:  Bao G Vu; Christopher S Stach; Wilmara Salgado-Pabón; Daniel J Diekema; Sue E Gardner; Patrick M Schlievert
Journal:  J Infect Dis       Date:  2014-06-20       Impact factor: 5.226

3.  Staphylococcus aureus, Toll-like receptors, superantigens, and their derivatives.

Authors:  Friedrich C Luft
Journal:  J Mol Med (Berl)       Date:  2012-10       Impact factor: 4.599

Review 4.  Targeting mucosal immunity in the battle to develop a mastitis vaccine.

Authors:  Mini Bharathan; Isis K Mullarky
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-10-04       Impact factor: 2.673

5.  Toxic effects of seu are different from those of other staphylococcal enterotoxins.

Authors:  Yi Li; Hui Deng; Pei-Dian Shi; Dan-Dan Xu; Li-Lin Zhang; Lei Zhang; Jin-Hai Huang
Journal:  Am J Transl Res       Date:  2017-04-15       Impact factor: 4.060

6.  Desialylation of airway epithelial cells during influenza virus infection enhances pneumococcal adhesion via galectin binding.

Authors:  Mihai Nita-Lazar; Aditi Banerjee; Chiguang Feng; Mohammed N Amin; Matthew B Frieman; Wilbur H Chen; Alan S Cross; Lai-Xi Wang; Gerardo R Vasta
Journal:  Mol Immunol       Date:  2015-01-16       Impact factor: 4.407

7.  A peptide antagonist of CD28 signaling attenuates toxic shock and necrotizing soft-tissue infection induced by Streptococcus pyogenes.

Authors:  Girish Ramachandran; Mohan E Tulapurkar; Kristina M Harris; Gila Arad; Anat Shirvan; Ronen Shemesh; Louis J Detolla; Cinzia Benazzi; Steven M Opal; Raymond Kaempfer; Alan S Cross
Journal:  J Infect Dis       Date:  2013-03-14       Impact factor: 5.226

8.  Cysteine proteinase from Streptococcus pyogenes enables evasion of innate immunity via degradation of complement factors.

Authors:  Mariko Honda-Ogawa; Taiji Ogawa; Yutaka Terao; Tomoko Sumitomo; Masanobu Nakata; Kazunori Ikebe; Yoshinobu Maeda; Shigetada Kawabata
Journal:  J Biol Chem       Date:  2013-04-15       Impact factor: 5.157

Review 9.  Device-Associated Menstrual Toxic Shock Syndrome.

Authors:  Patrick M Schlievert; Catherine C Davis
Journal:  Clin Microbiol Rev       Date:  2020-05-27       Impact factor: 26.132

10.  Norepinephrine potentiates proinflammatory responses of human vaginal epithelial cells.

Authors:  Amanda J Brosnahan; Lucy Vulchanova; Samantha R Witta; Yuying Dai; Bryan J Jones; David R Brown
Journal:  J Neuroimmunol       Date:  2013-04-06       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.